BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 25591737)

  • 1. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
    Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
    Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance.
    Buhlman L; Damiano M; Bertolin G; Ferrando-Miguel R; Lombès A; Brice A; Corti O
    Biochim Biophys Acta; 2014 Sep; 1843(9):2012-26. PubMed ID: 24878071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance.
    Bertolin G; Ferrando-Miguel R; Jacoupy M; Traver S; Grenier K; Greene AW; Dauphin A; Waharte F; Bayot A; Salamero J; Lombès A; Bulteau AL; Fon EA; Brice A; Corti O
    Autophagy; 2013 Nov; 9(11):1801-17. PubMed ID: 24149440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
    Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
    Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
    Eldeeb MA; Ragheb MA
    Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endoplasmic reticulum/mitochondria interface: a subcellular platform for the orchestration of the functions of the PINK1-Parkin pathway?
    Erpapazoglou Z; Corti O
    Biochem Soc Trans; 2015 Apr; 43(2):297-301. PubMed ID: 25849933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase.
    Birsa N; Norkett R; Wauer T; Mevissen TE; Wu HC; Foltynie T; Bhatia K; Hirst WD; Komander D; Plun-Favreau H; Kittler JT
    J Biol Chem; 2014 May; 289(21):14569-82. PubMed ID: 24671417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
    Rakovic A; Grünewald A; Seibler P; Ramirez A; Kock N; Orolicki S; Lohmann K; Klein C
    Hum Mol Genet; 2010 Aug; 19(16):3124-37. PubMed ID: 20508036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1/Parkin-mediated mitophagy.
    Ma KY; Fokkens MR; Reggiori F; Mari M; Verbeek DS
    Transl Neurodegener; 2021 Jun; 10(1):19. PubMed ID: 34127073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGAM5 regulates PINK1/Parkin-mediated mitophagy via DRP1 in CCCP-induced mitochondrial dysfunction.
    Park YS; Choi SE; Koh HC
    Toxicol Lett; 2018 Mar; 284():120-128. PubMed ID: 29241732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson's disease.
    Shiba-Fukushima K; Ishikawa KI; Inoshita T; Izawa N; Takanashi M; Sato S; Onodera O; Akamatsu W; Okano H; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(16):3172-3185. PubMed ID: 28541509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkin recruitment to impaired mitochondria for nonselective ubiquitylation is facilitated by MITOL.
    Koyano F; Yamano K; Kosako H; Tanaka K; Matsuda N
    J Biol Chem; 2019 Jun; 294(26):10300-10314. PubMed ID: 31110043
    [No Abstract]   [Full Text] [Related]  

  • 16. The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1/PARK2 pathway.
    Gao F; Chen D; Si J; Hu Q; Qin Z; Fang M; Wang G
    Hum Mol Genet; 2015 May; 24(9):2528-38. PubMed ID: 25612572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mutations and functions of PINK1.
    Kawajiri S; Saiki S; Sato S; Hattori N
    Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of PTEN-L in Modulating PINK1-Parkin-Mediated Mitophagy.
    Eldeeb MA; Esmaili M; Hassan M; Ragheb MA
    Neurotox Res; 2022 Aug; 40(4):1103-1114. PubMed ID: 35699891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin and PINK1 functions in oxidative stress and neurodegeneration.
    Barodia SK; Creed RB; Goldberg MS
    Brain Res Bull; 2017 Jul; 133():51-59. PubMed ID: 28017782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.